Setting 
My Cart
Toggle Nav
Close
  • Menu
  • Setting

JAK/STAT Signaling

The JAK (Janus kinase) / STAT (signal transducer and activator of transcription) signaling pathway transduce signals that are essential for development, cellular differentiation and homeostasis. This pathway plays a critical role in cytokine receptor systems, regulating growth, survival and pathogen resistance. JAK is a family of non-receptor protein tyrosine kinases, consisting of JAK1, JAK2, JAK3 and TYK2 (Tyrosine Kinase-2). STATs are transcription factors that activated following recruitment to an activated receptor complex, seven STAT proteins have been identified: STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B and STAT6.

Various ligands including cytokines (e.g. interferons and interleukins), hormones (e.g. erythropoietin and growth hormone) and their cell surface receptors activate JAK proteins, which autophosphorylate, and then phosphorylate the receptor. Subsequently, JAKs phosphorylate a specific tyrosine residue on the STAT protein, promoting dimerization via SH2 domains. The activated STATs form homo-/heterodimers and translocate to the nucleus to trigger target gene transcription. In addition, suppressors of cytokine signaling (SOCS) family inhibit receptor signaling via homologous or heterologous feedback regulation. Dysregulation in JAK/STAT signaling is associated with diseases such as atherosclerosis, immunodeficiencies and cancer.

Items 161-170 of 183

Page
per page
  1. Phellopterin
    BA8685 Phellopterin
    Summary: An orally active furocoumarin that acts as a partial agonist of central benzodiazepine receptors, with anti-inflammatory activity via SIRT1 upregulation
      ≥39.2 mg/mL
  2. Tropisetron
    BA5012 Tropisetron
    Summary: A 5-HT3 receptor antagonist
      ≥17.23 mg/mL
  3. Avitinib maleate
    A8980 Avitinib maleate
    Summary: A third-generation EGFR and BTK dual-target irreversible inhibitor with oral activity.
      Soluble in DMSO
  4. Astaxanthin
    B8611 Astaxanthin
    Summary: A carotenoid with antioxidant, anti-inflammatory, anticancer, and feed coloring effects.
      insoluble in H2O; insoluble in DMSO; insoluble in EtOH
  5. Glycochenodeoxycholic Acid (sodium salt)
    C3359 Glycochenodeoxycholic Acid (sodium salt)
    Summary: A bile acid metabolism modulator for research on cholestasis, liver cancer, and PSC.
      ≥26.2 mg/mL
  6. WKYMVM-NH2 TFA
    C8818 WKYMVM-NH2 TFA
    Summary: Selective agonist of formyl peptide receptors (FPRs)
      ≥53.4 mg/mL
  7. AK-1690
    C8937 AK-1690
    Summary: A selective PROTAC degrader targeting STAT6
      ≥51 mg/mL
  8. Iminostilbene
    C8848 Iminostilbene
    Summary: Iminostilbene is a tricyclic dibenzazepine scaffold compound used as a synthetic intermediate and reference standard in neuropharmacology and medicinal chemistry research.
      ≥35.5 mg/mL
  9. Flurbiprofen Axetil
    C8908 Flurbiprofen Axetil
    Summary: Flurbiprofen Axetil is a lipophilic prodrug of the nonselective cyclooxygenase inhibitor flurbiprofen, used to investigate prostaglandin-mediated inflammatory signaling in pharmacology research.
  10. Ritlecitinib (PF-06651600)
    C8918 Ritlecitinib (PF-06651600)
    Summary: Ritlecitinib (PF-06651600; CAS 1792180-81-4) is a selective covalent JAK3/TEC family kinase inhibitor used to investigate cytokine signaling and immune-cell pathway biology.

Items 161-170 of 183

Page
per page